Company
Headquarters: Beijing, China
Employees: 621
CN¥3.97 Billion
CNY as of Jan. 1, 2025
US$543.8 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulatory, nervous systems, and other areas. The company was founded in 1999 and is headquartered in Beijing, China.
Beijing Science Sun Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300485 wb_incandescent